|
MLLT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.19744231092045E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6707746297584E-12 |
| Normal-vs-Stage2 |
6.6259220332654E-12 |
| Normal-vs-Stage3 |
1.63502544836547E-12 |
| Normal-vs-Stage4 |
1.62547753035369E-12 |
| Stage1-vs-Stage2 |
1.389450E-01 |
| Stage1-vs-Stage3 |
3.579600E-01 |
| Stage1-vs-Stage4 |
5.024400E-02 |
| Stage2-vs-Stage3 |
7.245600E-02 |
| Stage2-vs-Stage4 |
6.055700E-03 |
| Stage3-vs-Stage4 |
3.056600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64313007644523E-14 |
| Normal-vs-AfricanAmerican |
1.3126000000252E-06 |
| Normal-vs-Asian |
1.68287606072681E-12 |
| Caucasian-vs-AfricanAmerican |
1.367610E-01 |
| Caucasian-vs-Asian |
6.456000E-01 |
| AfricanAmerican-vs-Asian |
2.111400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7856827128071E-12 |
| Normal-vs-Female |
2.08721928629529E-14 |
| Male-vs-Female |
3.619200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.67110769666579E-12 |
| Normal-vs-Age(41-60Yrs) |
1.6547874182038E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63136171238421E-12 |
| Normal-vs-Age(81-100Yrs) |
7.961900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.905800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.057400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.200800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.187800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.639000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.589200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.77045094935147E-13 |
| Classical-VS-Follicular |
4.438000E-01 |
| Classical-VS-Other |
8.028200E-01 |
| Classical-VS-Normal |
1.78190795452338E-13 |
| Tall-VS-Follicular |
1.09700000194835E-08 |
| Tall-VS-Other |
1.504760E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.651800E-01 |
| Follicular-VS-Normal |
1.89248616777604E-12 |
| Other-VS-Normal |
4.831600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.21884749357559E-13 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
1.7662400000007E-05 |
|
|
